The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?

David G. T. Whitehurst (), John E. Brazier, Rosalie Viney () and Brendan J. Mulhern
Additional contact information
David G. T. Whitehurst: Simon Fraser University
John E. Brazier: University of Sheffield
Brendan J. Mulhern: University of Technology Sydney

PharmacoEconomics, 2020, vol. 38, issue 12, No 2, 1283-1288

Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-020-00957-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00957-9

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-020-00957-9

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().